OPEN END TURBO LONG - BICO GROUP B Stock

Certificat

DE000MG22HG3

Market Closed - Börse Stuttgart 06:22:38 2024-05-31 EDT
0.135 EUR +2.27% Intraday chart for OPEN END TURBO LONG - BICO GROUP B
Current month-10.60%
1 month-10.60%
Date Price Change
24-05-31 0.135 +2.27%
24-05-30 0.132 +0.76%
24-05-29 0.131 -12.08%
24-05-28 0.149 -6.29%
24-05-27 0.159 +13.57%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 06:22 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BICO GROUP AB
Issuer Morgan Stanley
WKN MG22HG
ISINDE000MG22HG3
Date issued 2024-04-10
Strike 30.38 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.168
Lowest since issue 0.059

Company Profile

BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Sector
-
More about the company

Ratings for BICO Group AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: BICO Group AB

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.82 SEK
Average target price
132.5 SEK
Spread / Average Target
+195.63%
Consensus